Financials Masimo Corporation

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
127 USD +1.80% Intraday chart for Masimo Corporation +2.34% +8.35%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,503 14,728 16,414 7,777 6,194 6,742 - -
Enterprise Value (EV) 1 7,815 14,087 15,668 7,777 6,194 4,740 5,002 4,836
P/E ratio 46.1 x 64.6 x 74.7 x 56.9 x 77.6 x 69.5 x 42.7 x 36.5 x
Yield - - - - - - - -
Capitalization / Revenue 9.07 x 12.9 x 13.2 x 3.82 x 3.02 x 3.21 x 3.03 x 2.85 x
EV / Revenue 8.33 x 12.3 x 12.6 x 3.82 x 3.02 x 2.26 x 2.25 x 2.05 x
EV / EBITDA 31.5 x 48.1 x 47.4 x 15.6 x 15.1 x 12 x 11.3 x 10.1 x
EV / FCF 51 x 102 x 65.5 x -389 x 124 x 23.4 x 16.6 x 12.3 x
FCF Yield 1.96% 0.98% 1.53% -0.26% 0.81% 4.27% 6.04% 8.15%
Price to Book 7.29 x 10.5 x 10.6 x - - - - -
Nbr of stocks (in thousands) 53,611 55,055 55,222 52,565 52,841 53,086 - -
Reference price 2 158.6 267.5 297.2 148.0 117.2 127.0 127.0 127.0
Announcement Date 2/19/20 2/23/21 2/15/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 937.8 1,144 1,239 2,036 2,048 2,098 2,226 2,363
EBITDA 1 248.2 292.9 330.5 498.3 411.3 394 442.6 477.1
EBIT 1 224.7 263.6 294.8 362.2 313 315.4 354.1 394.8
Operating Margin 23.96% 23.05% 23.79% 17.79% 15.28% 15.03% 15.91% 16.71%
Earnings before Tax (EBT) 1 234.2 263.7 274.4 193.4 88.1 139.1 212.5 255.6
Net income 1 196.2 240.3 229.6 143.5 81.5 99.02 163.4 198.1
Net margin 20.92% 21.01% 18.53% 7.05% 3.98% 4.72% 7.34% 8.38%
EPS 2 3.440 4.140 3.980 2.600 1.510 1.828 2.974 3.480
Free Cash Flow 1 153.3 138.4 239.3 -20 50.1 202.3 302.2 394.3
FCF margin 16.34% 12.1% 19.31% -0.98% 2.45% 9.64% 13.58% 16.69%
FCF Conversion (EBITDA) 61.76% 47.25% 72.4% - 12.18% 51.34% 68.27% 82.64%
FCF Conversion (Net income) 78.11% 57.6% 104.18% - 61.47% 204.31% 184.97% 199.02%
Dividend per Share - - - - - - - -
Announcement Date 2/19/20 2/23/21 2/15/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 327.6 304.2 565.3 549.3 617 565 455.3 478.9 548.9 492.8 493.9 508.5 602.7 519.9 527.4
EBITDA 1 93.41 78.96 176.8 58 183.9 101.6 83.8 81.4 114.2 92.2 84.64 91.28 126.2 96.63 104.5
EBIT 1 84.24 69.82 106 81.3 104.4 75.5 58.6 56.9 91.7 67.9 68.92 75.73 102.9 78.84 81.14
Operating Margin 25.71% 22.95% 18.75% 14.8% 16.92% 13.36% 12.87% 11.88% 16.71% 13.78% 13.96% 14.89% 17.07% 15.16% 15.39%
Earnings before Tax (EBT) 1 76.7 59.14 26.6 52 55.7 26.2 24.8 14 23.2 24.9 21.06 31.78 61.36 42.22 40.12
Net income 1 68.26 46.6 18.1 37.9 41.1 21.3 15.7 10.6 34 18.9 14.08 21.87 42.44 35.11 35.76
Net margin 20.84% 15.32% 3.2% 6.9% 6.66% 3.77% 3.45% 2.21% 6.19% 3.84% 2.85% 4.3% 7.04% 6.75% 6.78%
EPS 2 1.180 0.8100 0.3300 0.7000 0.7600 0.3900 0.2900 0.2000 0.6300 0.3500 0.2583 0.3967 0.7683 0.6333 0.6400
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/15/22 5/3/22 8/9/22 11/8/22 2/28/23 5/9/23 8/8/23 11/7/23 2/27/24 5/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 688 641 745 - - 2,001 1,740 1,906
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 153 138 239 -20 50.1 202 302 394
ROE (net income / shareholders' equity) 18.4% 18.7% 15.5% - - - - -
ROA (Net income/ Total Assets) 15.4% 15.5% 12.8% - - - - -
Assets 1 1,276 1,554 1,800 - - - - -
Book Value Per Share 21.80 25.50 28.00 - - - - -
Cash Flow per Share 3.880 - 4.590 0.5300 - - - -
Capex 1 68.4 72.5 25.5 49.5 - 51.5 72.1 75.1
Capex / Sales 7.29% 6.34% 2.06% 2.43% - 2.45% 3.24% 3.18%
Announcement Date 2/19/20 2/23/21 2/15/22 2/28/23 2/27/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
127 USD
Average target price
151.9 USD
Spread / Average Target
+19.60%
Consensus
  1. Stock Market
  2. Equities
  3. MASI Stock
  4. Financials Masimo Corporation